Inborn metabolic brain diseases arise from disturbances in body chemistry due to an alteration in the metabolic cycle. A disturbance in the brain’s chemical environment in the form of a deficiency or the buildup of metabolites leading to the spread of toxins can lead to a metabolic disorder, which can be expressed in many forms such as impaired brain development, cerebral palsy and seizures. Inborn metabolic brain diseases can occur in the fetus due to a nutritional deficiency or alcohol use of the mother. Metabolic brain diseases can also be passed on genetically, typically in an autosomal recessive manner, but can also arise from spontaneous mutations in utero. The majority of metabolic brain diseases occur in infants. Treatment for many metabolic brain diseases is still being researched, but many doctors will attempt to restore the chemical balance of the brain in order to reverse the effects of the symptoms.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Brain Diseases, Metabolic, Inborn below!
For more information on how to use Laverne, please read the How to Guide.
We have 617 products for the study of Brain Diseases, Metabolic, Inborn that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Brain Diseases, Metabolic, Inborn is also known as Inborn Errors Of Metabolism, Brain, Inborn Metabolic Brain Diseases.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.